Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Rules and Regulations 30081 

Congressional Review Act. This rule has 

not been designated as a ‘‘significant 

regulatory action’’ under Executive 

Order 12866. Accordingly, this rule has 

not been reviewed by the Office of 

Management and Budget (OMB). 

Executive Order 13771, titled 

‘‘Reducing Regulation and Controlling 

Regulatory Costs,’’ was issued on 

January 30, 2017. HHS identifies this 

final rule as a deregulatory action 

(removing an obsolete rule from the 

Code of Federal Regulations). For the 

purposes of Executive Order 13771, this 

final rule is not a substantive rule; 

rather it is administrative in nature and 

provides no cost savings. 

Executive Order 13777, titled 

‘‘Enforcing the Regulatory Reform 

Agenda,’’ was issued on February 24, 

2017. As required by Section 3 of this 

Executive Order, HHS established a 

Regulatory Reform Task Force (HHS 

Task Force). Pursuant to Section 3(d)(ii), 

the HHS Task Force evaluated this 

rulemaking and determined that these 

regulations are ‘‘outdated, unnecessary, 

or ineffective.’’ Following this finding, 

the HHS Task Force advised the HRSA 

Administrator to initiate this 

rulemaking to remove the obsolete 

regulations from the Code of Federal 

Regulations. 

Regulatory Flexibility Act 

This action will not have a significant 

economic impact on a substantial 

number of small entities. Therefore, the 

regulatory flexibility analysis provided 

for under the Regulatory Flexibility Act 

is not required. 

Paperwork Reduction Act 

This action does not affect any 

information collections. 

Dated: June 4, 2018. 

George Sigounas, 

Administrator, Health Resources and Services 

Administration. 

Approved: June 21, 2018. 

Alex M. Azar II, 

Secretary, Department of Health and Human 

Services. 

List of Subjects in 42 CFR Part 23 

Health, Health professions. 

For reasons set out in the preamble, 

and under the authority at 5 U.S.C. 301, 

HHS amends 42 CFR part 23 as follows: 

PART 23—NATIONAL HEALTH 

SERVICE CORPS 

■ 1. The authority citation for part 23 

continues to read as follows: 

Authority: Secs. 333, 338E(c), and 

338C(e)(1), Public Health Service Act. 90 

Stat. 2272, as amended, 95 Stat. 905, 97 Stat. 

1345 (42 U.S.C. 254f et seq.), 95 Stat. 912 (42 

U.S.C. 254p(c)), 95 Stat. 910 (42 U.S.C. 

254n(e)(1)). 

Subparts B and C [Removed] 

■ 2. Remove subpart B, consisting of 

§§ 23.21 through 23.35, and subpart C, 

consisting of § 23.41. 

[FR Doc. 2018–13837 Filed 6–26–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

42 CFR Part 130 

RIN 0906–AB13 

Removing Outmoded Regulations 

Regarding the Ricky Ray Hemophilia 

Relief Fund Program 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Final rule. 

SUMMARY: This action removes the 

outmoded regulations for the Ricky Ray 

Hemophilia Relief Fund Program. The 

program and its implementing 

regulation have been rendered obsolete 

by the statutory language in the 

authorizing legislation stating that the 

Fund should terminate on the 

expiration of the 5-year period 

beginning on the date of the enactment 

of the Act. The statute was enacted on 

November 12, 1998; thus, the fund 

expired on November 12, 2003. 

DATES: This action is effective July 27, 

2018. 

FOR FURTHER INFORMATION CONTACT: 

Sweta Maheshwari J.D., Legislative 

Analyst, Division of Policy and Shortage 

Designation, Bureau of Health 

Workforce, HRSA, 5600 Fishers Lane, 

Room 11W21A, Rockville, MD 20857, 

by phone at (301) 945–3527, or by email 

at smaheshwari@hrsa.gov. 

SUPPLEMENTARY INFORMATION: In 

response to Executive Order 13563, Sec. 

6(a), which urges agencies to repeal 

existing regulations that are outmoded 

from the Code of Federal Regulations 

(CFR), HHS is removing 42 CFR part 

130. HHS believes that there is good 

cause to bypass notice and comment 

and proceed to a final rule, pursuant to 

5 U.S.C. 553(b)(3)(B). The action is noncontroversial, as it merely removes a 

provision from the CFR that is obsolete. 

This rule poses no new substantive 

requirements on the public. 

Background 

The Ricky Ray Hemophilia Relief 

Fund Act of 1998 (Pub. L. 105–369) 

established the Ricky Ray Hemophilia 

Relief Fund Program designed to 

provide payments to individuals with 

blood-clotting disorders, such as 

hemophilia, who contracted HIV 

through the use of antihemophilic factor 

administered between July 1, 1982, and 

December 31, 1987. The Act also 

provided for payments to certain 

persons who contracted HIV from an 

individual as described above and 

certain specified survivors. 

HHS promulgated 42 CFR part 130 to 

establish the proper regulatory 

framework for program implementation. 

The regulation can be conceptualized as 

four parts: The process for payment, the 

documentation required to prove 

eligibility, the petition process, and the 

reconsideration process. The Ricky Ray 

Hemophilia Relief Fund was authorized 

with a directive to pay $100,000 in 

compensation to eligible individuals. At 

that time, however, no funds were 

appropriated to implement this statute. 

In FY 2000, Congress appropriated $75 

million and, in FY 2001, Congress 

appropriated $580 million, for a total of 

$655 million. The appropriated amounts 

provided sufficient funding to make 

compassionate payments on all eligible 

petitions received by the program. The 

program received over 6,000 petitions 

resulting in approved payments over 

$550 million. 

The statutory language in the 

authorizing legislation stated that the 

‘‘Fund shall terminate upon the 

expiration of the 5-year period 

beginning on the date of the enactment 

of this Act.’’ The statute was enacted on 

November 12, 1998; thus, the fund 

expired on November 12, 2003. The 

program is no longer in effect or funded. 

The repeal of this regulation should not 

create any challenges for other 

programs, as the regulation was strictly 

for the implementation of the Ricky Ray 

Hemophilia Relief Fund program, which 

has not been in operation for almost 14 

years. 

Executive Orders 12866, 13563, 13771, 

and 13777 

Executive Orders 12866 and 13563 

direct agencies to assess all costs and 

benefits of available regulatory 

alternatives and, if regulation is 

necessary, to select regulatory 

approaches that maximize net benefits 

(including potential economic, 

environmental, public health and safety 

effects, distributive impacts, and 

equity). Executive Order 13771 directs 

agencies to categorize all impacts which 

generate or alleviate costs associated 

with regulatory burden and to 

determine the actions net incremnatal 

effect. 


nshattuck on DSK9F9SC42PROD with RULES
30082 Federal Register / Vol. 83, No. 124 / Wednesday, June 27, 2018 / Rules and Regulations 

Section 3(f) of Executive Order 12866 

defines a ‘‘significant regulatory action’’ 

as an action that is likely to result in a 

rule: (1) Having an annual effect on the 

economy of $100 million or more in any 

1 year, or adversely and materially 

affecting a sector of the economy, 

productivity, competition, jobs, the 

environment, public health or safety, or 

State, local or Tribal governments or 

communities (also referred to as 

‘‘economically significant’’); (2) creating 

a serious inconsistency or otherwise 

interfering with an action taken or 

planned by another agency; (3) 

materially altering the budgetary 

impacts of entitlement grants, user fees, 

or loan programs or the rights and 

obligations of recipients thereof; or (4) 

raising novel legal or policy issues 

arising out of legal mandates, the 

President’s priorities, or the principles 

set forth in the Executive Order. 

A regulatory impact analysis (RIA) 

must be prepared for major rules with 

economically significant effects ($100 

million or more in any 1 year). HHS 

submits that this final rule is not 

‘‘economically significant’’ as measured 

by the $100 million threshold, and 

hence not a major rule under the 

Congressional Review Act. This rule has 

not been designated as a ‘‘significant 

regulatory action’’ under Executive 

Order 12866. Accordingly, this rule has 

not been reviewed by the Office of 

Management and Budget (OMB). 

Executive Order 13771, titled 

‘‘Reducing Regulation and Controlling 

Regulatory Costs,’’ was issued on 

January 30, 2017. HHS identifies this 

final rule as a deregulatory action 

(removing an obsolete rule from the 

Code of Federal Regulations). For the 

purposes of Executive Order 13771, this 

final rule is not a substantive rule; 

rather it is administrative in nature and 

provides no cost savings. 

Executive Order 13777, titled 

‘‘Enforcing the Regulatory Reform 

Agenda,’’ was issued on February 24, 

2017. As required by Section 3 of this 

Executive Order, HHS established a 

Regulatory Reform Task Force (HHS 

Task Force). Pursuant to Section 3(d)(ii), 

the HHS Task Force evaluated this 

rulemaking and determined that these 

regulations are ‘‘outdated, unnecessary, 

or ineffective.’’ Following this finding, 

the HHS Task Force advised the HRSA 

Administrator to initiate this 

rulemaking to remove the obsolete 

regulations from the Code of Federal 

Regulations. 

Regulatory Flexibility Act 

This action will not have a significant 

economic impact on a substantial 

number of small entities. Therefore, the 

regulatory flexibility analysis provided 

for under the Regulatory Flexibility Act 

is not required. 

Paperwork Reduction Act 

This action does not affect any 

information collections. 

Dated: June 4, 2018. 

George Sigounas, 

Administrator, Health Resources and Services 

Administration. 

Approved: June 21, 2018. 

Alex M. Azar II, 

Secretary, Department of Health and Human 

Services. 

List of Subjects in 42 CFR Part 130 

Health care, Hemophilia, HIV/AIDS. 

PART 130—[REMOVED] 

■ For reasons set out in the preamble, 

and under the authority at 5 U.S.C. 301, 

HHS amends 42 CFR chapter I by 

removing part 130. 

[FR Doc. 2018–13836 Filed 6–26–18; 8:45 am] 

BILLING CODE 4165–15–P 

FEDERAL COMMUNICATIONS 

COMMISSION 

47 CFR Part 64 

[CG Docket Nos. 13–24 and 03–123; FCC 

18–79] 

IP CTS Modernization and Reform 

AGENCY: Federal Communications 

Commission. 

ACTION: Final rule and clarification. 

SUMMARY: In this document, the 

Commission alters the methodology for 

setting provider compensation rates for 

internet Protocol Captioned Telephone 

Service (IP CTS) and establishes interim 

compensation rates for Fund Years 

2018–19 and 2019–20. The Commission 

also adopts rules that address the 

provision of volume control on IP CTS 

devices, require the accuracy of IP CTS 

information disseminated by providers, 

and prohibit the provision of service to 

ineligible users. Finally, the 

Commission declares that speech-to-text 

automation, without the participation of 

a communications assistant (CA), may 

be used to generate IP CTS captions. 

DATES:

Effective dates: 47 CFR 64.604(c)(10) 

and (c)(13)(i)–(ii) are effective July 27, 

2018. The Commission will publish a 

document in the Federal Register 

announcing the effective date of 47 CFR 

64.604(c)(11)(v) and the amendments to 

47 CFR 64.604(c)(5)(iii)(D)(1), (6), and 

(c)(13)(iii)–(iv) of the Commission’s 

rules, which contain modified 

information collection requirements that 

have not yet been approved by the 

Office of Management and Budget 

(OMB) under the Paperwork Reduction 

Act of 1995 (PRA), Public Law 104–13. 

The IP CTS compensation rate adopted 

for the 2018–19 Fund Year shall be 

effective July 1, 2018. 

Applicability date: IP CTS providers 

must comply with the requirement to 

ensure that any volume control or other 

amplification feature can be adjusted 

separately and independently of the 

caption feature on or before December 8, 

2018. 

FOR FURTHER INFORMATION CONTACT: 

Michael Scott, Consumer and 

Governmental Affairs Bureau, FCC, at 

(202) 418–1264, or email 

Michael.Scott@fcc.gov. 

SUPPLEMENTARY INFORMATION: This is a 

summary of the Commission’s Report 

and Order and Declaratory Ruling in CG 

Docket Nos. 03–123 and 13–24; 

document FCC 18–79, adopted on June 

7, 2018 and released on June 8, 2018. 

Document FCC 18–79 concerns the 

modernization and reform of the 

Commission’s rules for IP CTS. The 

Commission previously sought 

comment on these issues in Misuse of 

internet Protocol (IP) Captioned 

Telephone Service; 

Telecommunications Relay Services and 

Speech-to-Speech Services for 

Individuals with Hearing and Speech 

Difficulties, published at 78 FR 54201, 

September 3, 2013 (2013 IP CTS Reform 

FNPRM). A Further Notice of Proposed 

Rulemaking (Further Notice) and Notice 

of Inquiry are contained in document 

FCC 18–79 and address additional 

issues concerning the funding, 

administration, and user eligibility for 

this service, as well as performance 

goals and metrics to ensure service 

quality for users. The Further Notice 

and Notice of Inquiry will be published 

elsewhere in the Federal Register. The 

full text of document FCC 18–79 will be 

available for public inspection and 

copying via the Commission’s 

Electronic Comment Filing System 

(ECFS), and during regular business 

hours at the FCC Reference Information 

Center, Portals II, 445 12th Street SW, 

Room CY–A257, Washington, DC 20554. 

To request materials in accessible 

formats for people with disabilities 

(Braille, large print, electronic files, 

audio format), send an email to fcc504@

fcc.gov, or call the Consumer and 

Governmental Affairs Bureau at (202) 

418–0530 (voice), (844) 432–2272 

(videophone), or (202) 418–0432 (TTY). 


nshattuck on DSK9F9SC42PROD with RULES